Investigation of piperidine derivatives in ex vivo models of pain and platelet aggregation

Archives of Pharmacal Research

Volumn 35, Issue 11, 2012, Pages 1953-1959

  Saify, Zafar Saeed ^a   Rasheed, Huma ^a   Mushtaq, Nousheen ^a   Nisa, Mehrun ^a   Haider, Shazia ^a   Naz, Afshan ^a   Azhar, Kaniz Fizza ^b   Miana, Ghulam Abbas ^c  

^a UNIVERSITY OF KARACHI   (Pakistan)

^b PCSIR LABORATORIES COMPLEX   (Pakistan)

^c RIPHAH INTERNATIONAL UNIVERSITY   (Pakistan)

Author keywords

Opoid receptor; Pain; Platelet activating factor; Platelet aggregation

Indexed keywords

4 (4' BROMO PHENYL) 4 HYDROXY 1 [2 (2'' NITRO PHENYL) 2 OXO ETHYL] PIPERIDINIUM BROMIDE; 4 (4' BROMO PHENYL) 4 HYDROXY 1 [2 (3'' NITRO PHENYL) 2 OXO ETHYL] PIPERIDINIUM BROMIDE; 4 (4' BROMO PHENYL) 4 HYDROXY 1 [2 (3'',4'' NITRO PHENYL) 2 OXO ETHYL] PIPERIDINIUM BROMIDE; 4 (4' BROMO PHENYL) 4 HYDROXY 1 [2 (4'' NITRO PHENYL) 2 OXO ETHYL] PIPERIDINIUM BROMIDE; 4 (4' BROMOPHENYL) 4 PIPERIDINOL; ACETYLSALICYLIC ACID; OPIATE RECEPTOR; PETHIDINE; PHENACYL DERIVATIVE; PIPERIDINE DERIVATIVE; PROSTAGLANDIN; THROMBOCYTE ANTIBODY; THROMBOXANE A2; UNCLASSIFIED DRUG;

ANALGESIA; ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CRYSTAL STRUCTURE; DRUG SYNTHESIS; EX VIVO STUDY; HUMAN; MOUSE; NONHUMAN; NORMAL HUMAN; PAIN; STRUCTURE ACTIVITY RELATION; THROMBOCYTE AGGREGATION;

EID: 84874442091     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-012-1112-9     Document Type: Article

References (21)

1. Becker, D.P.; Villamil, C. I.; Barta, T. E.; Bedell, L. J.; Boehm, T. L.; Decrescenzo, G. A.; Freskos, J. N.; Getman, D. P.; Hockerman, S.; Heintz, R.; Howard, S. C.; Li, M. H.; McDonald, J. J.; Carron, C. P.; Funckes-Shippy, C. L.; Mehta, P. P.; Munie, G. E.; and Swearingen, C. A.; Synthesis and structure-activity relationships of beta- and alpha-piperidine sulfone hydroxamic acid matrix metalloproteinase inhibitors with oral antitumor efficacy. J. Med. Chem.; 48, 6713-6730 (2005).
2. DesJarlais, R.L.; Sheridan, R. P.; Seibel, G. L.; Dixon, J. S.; Kuntz, I. D.; and Venkataraghavan, R.; Docking: successes and challenges. J. Med. Chem.; 31, 722-729 (1988).
3. Di Stasi, L.C.; Costa, M.; Mendaçolli, S. L.; Kirizawa, M.; Gomes, C.; and Trolin, G.; Screening in mice of some medicinal plants used for analgesic purposes in the state of São Paulo. J. Ethnopharmacol.; 24, 205-211 (1988).
4. Erol, D.D. and Demirdamar, R.; Analgesic and anti-inflammatory activity screening of 6-acyl-3-piperidinomethyl-2(3H)-benzoxazolone derivatives. Farmaco, 49, 663-666 (1994).
5. Feng, Z.; Gollamudi, R.; Dillingham, E. O.; Bond, S. E.; Lyman, B. A.; Purcell, W. P.; Hill, R. J.; and Korfmacher, W. A.; Molecular determinants of the platelet aggregation inhibitory activity of carbamoylpiperidines. J. Med. Chem.; 35, 2952-2958 (1992).
6. Guo, Z.; Zheng, X.; Thompson, W.; Dugdale, M.; and Gollamudi, R.; New carbamoylpiperidines as human platelet aggregation inhibitors. Bioorg. Med. Chem.; 8, 1041-1058 (2000).
7. Imamura, S.; Nishikawa, Y.; Ichikawa, T.; Hattori, T.; Matsushita, Y.; Hashiguchi, S.; Kanzaki, N.; Iizawa, Y.; Baba, M.; and Sugihara, Y.; CCR5 antagonists as anti-HIV-1 agents. Part 3. Synthesis and biological evaluation of piperidine-4-carboxamide derivatives. Bioorg. Med. Chem.; 13, 397-416 (2005).
8. Jones, G.; Willett, P.; Glen, R. C.; Leach, A. R.; and Taylor, R.; Development and validation of a genetic algorithm for flexible. J. Mol. Biol.; 267, 727-748 (1997).
9. Kordik, C.P.; Luo, C.; Gutherman, M.; Vaidya, A. H.; Rosenthal, D. I.; Crooke, J. J.; McKenney, S. L.; Plata-Salaman, C. R.; and Reitz, A. B.; Diarylacetylene piperidinyl amides as novel anxiolytics. Bioorg. Med. Chem. Lett.; 16, 3065-3067 (2006).
10. Köksal, M. and Bilge, S. S.; Synthesis and antidepressantlike profile of novel 1-aryl-3-[(4-benzyl) piperidine-1-yl] propane derivatives. Arch. Pharm. (Weinheim), 340, 299-303 (2007).
11. Lawrence, W.P.; Howell, R. D.; and Gollamudi, R.; Antiplatelet activity of nipecotamides in experimental thrombosis in mice. J. Pharm. Sci.; 83, 222-225 (1994).
12. Miguel, O.G.; Santos, A. R.; Calixto, J. B.; Delle Monache, F.; and Yunes, R. A.; Antinociceptive activity of the natural piperidine alkaloid hydrochlorides from Syphocampylus verticellatus. Z. Naturforsch. C, 57, 81-84 (2002).
13. Montrucchio, G.; Alloattig, G.; and Camussi, G.; Role of platelet-activating factor in cardiovascular pathophysiology. Physiol. Rev.; 1669-1699 (2000).
14. Mushtaq, N.; Saify, Z. S.; Akhtar, S.; Arif, M.; Haider, S.; and Saba, N.; Synthesis of some novel analogues of 4-(1-pyrrolidinyl) Perpridine and their effects on plasma glucose level. Pak. J. Phar. Sci.; 23, 220-223 (2010).
15. Ramachandran, R.; Rani, M.; Senthan, S.; Jeong, Y. T.; and Kabilan, S.; Biological activity of piperidine derivatives. Eur. J. Med. Chem.; 46, 1926-1934 (2011).
16. Rasheed, H.; Tirmizi, A. H.; Salahuddin, F.; Rizvi, N. B.; Arshad, F.; Farooq, S. Z.; and Saeed, S. A.; Calcium signaling in human platelet aggregation mediated by platelet activating factor and calcium ionophore, A23187. J. Biol. Sci.; 4, 117-121 (2004a).
17. Rasheed, H. and Saeed, S. A.; Involvement of thromboxane A2 and tyrosine kinase in the synergistic interaction of platelet activating factor and calcium ionophore A23187 in human platelet aggregation. Exp. Mol. Med.; 36, 220-225 (2004b).
18. Saeed, M.; Saify, Z. S.; Gilani, A. H.; Haider, M. S.; and Iqbal, Z.; Studies on the effects of piperidine derivatives on blood pressure and smooth muscles contractions. Arch. Pharm. Res.; 21, 370-373 (1998).
19. Saify, Z.S.; Nisa, M.; Azhr, K. F.; Azim, M. K.; Rasheed, H.; Mushtaq, N.; Arain, M. A.; Haider, S.; Khanum, M.; and Ahmed, W.; Characterization of plasmodium falciparum aspartic protease inhibition by piperidine derivatives. Nat. Prod. Res.; 25, 1965-1968 (2011).
20. Thaler, F.; Varasi, M.; Carenzi, G.; Colombo, A.; Abate, A.; Bigogno, C.; Boggio, R.; Carrara, S.; Cataudella, R. D. F.; Reali, V.; Vultaggio, S.; Dondio, G.; Gagliardi, S.; and Mercurio, C.; Spiro [chromane-2,4′- piperidine]-based histone deacetylase inhibitors with improved in vivo activity. Chem. Med. Chem.; 7, 709-21 (2012).
21. Zheng, X.; Salgia, S. R.; Thompson, W. B.; Dillingham, E. O.; Bond, S. E.; Feng, Z.; Prasad, K. R.; and Gollamudi, R.; Design and synthesis of piperidine-3-carboxamides as human platelet aggregation inhibitors. J. Med. Chem.; 38, 180-188 (1995).